FDA approves deflazacort for muscular dystrophy patients
The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »
The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »
The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »
The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes. Read More »
The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities. Read More »
Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »
Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »
Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »
"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »
Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »
The Center for Medicaid and CHIP Services is encouraging pharmacies to extend the scope of dispensing medications to foster immediate access to certain drugs. Read More »
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
The National Institute of Allergy and Infectious Diseases recently released new guidelines to help health care providers and family members manage and prevent peanut allergies in infants. Read More »
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
The American Journal of Health-System Pharmacy has applauded the 21st Century Cures Act was signed into law by President Barack Obama on Dec. 13. Read More »
Direct Relief recently announced that it airlifted 82 tons of medical aid to Haiti for the treatment of cholera and other diseases that have become rampant since Hurricane Matthew in October. Read More »
Intrarosa (prasterone), which is designed for women who experience moderate to severe pain during sex, has been approved by the U.S. Food and Drug Administration. Read More »
Akebia Therapeutics Inc. and Otsuka Pharmaceutical Co. Ltd. recently entered a collaboration and license agreement in the U.S. for vadadustat, an oral hypoxia-inducible factor stabilizer in development for the treatment of anemia associated with chronic kidney disease Read More »